Sector Gamma As Raised Abbott Labs (ABT) Position By $1.52 Million; 2 Analysts Are Bullish Electrocomponents plc (LON:ECM) Last Week

August 10, 2018 - By William Brooks

Electrocomponents plc (LON:ECM) Logo

Among 8 analysts covering Electrocomponents PLC (LON:ECM), 2 have Buy rating, 1 Sell and 5 Hold. Therefore 25% are positive. Electrocomponents PLC had 16 analyst reports since March 29, 2018 according to SRatingsIntel. On Thursday, July 5 the stock rating was maintained by Liberum Capital with “Buy”. HSBC downgraded it to “Hold” rating and GBX 800 target in Tuesday, June 5 report. The firm earned “Add” rating on Monday, April 9 by Peel Hunt. The firm has “Buy” rating given on Thursday, July 5 by Numis Securities. The rating was maintained by Jefferies with “Hold” on Monday, August 6. The firm has “Neutral” rating given on Wednesday, July 4 by UBS. The firm earned “Add” rating on Thursday, April 5 by Peel Hunt. The firm earned “Add” rating on Thursday, May 24 by Peel Hunt. The firm earned “Hold” rating on Thursday, July 12 by Berenberg. The stock has “Buy” rating by Liberum Capital on Thursday, April 5. See Electrocomponents plc (LON:ECM) latest ratings:

06/08/2018 Broker: Jefferies Rating: Hold Old Target: GBX 600.00 New Target: GBX 740.00 Maintain
12/07/2018 Broker: Berenberg Rating: Hold Old Target: GBX 590.00 New Target: GBX 770.00 Reiteration
05/07/2018 Broker: Numis Securities Rating: Buy Old Target: GBX 945.00 Maintain
05/07/2018 Broker: Peel Hunt Rating: Hold Old Target: GBX 690.00 New Target: GBX 710.00 Downgrade
05/07/2018 Broker: Liberum Capital Rating: Buy Old Target: GBX 780.00 Maintain
04/07/2018 Broker: UBS Rating: Neutral Old Target: GBX 745.00 Maintain
21/06/2018 Broker: Numis Securities Rating: Buy Old Target: GBX 705.00 New Target: GBX 945.00 Upgrade
11/06/2018 Broker: Liberum Capital Rating: Buy Old Target: GBX 690.00 New Target: GBX 780.00 Maintain
05/06/2018 Broker: HSBC Rating: Hold Old Target: GBX 745.00 New Target: GBX 800.00 Downgrade
24/05/2018 Broker: Peel Hunt Rating: Add Old Target: GBX 690.00 Maintain

Sector Gamma As increased Abbott Labs (ABT) stake by 2.39% reported in 2018Q1 SEC filing. Sector Gamma As acquired 25,800 shares as Abbott Labs (ABT)’s stock rose 3.04%. The Sector Gamma As holds 1.11 million shares with $66.25M value, up from 1.08 million last quarter. Abbott Labs now has $113.15 billion valuation. The stock decreased 0.22% or $0.14 during the last trading session, reaching $64.5. About 154,383 shares traded. Abbott Laboratories (NYSE:ABT) has risen 41.91% since August 10, 2017 and is uptrending. It has outperformed by 29.34% the S&P500. Some Historical ABT News: 18/05/2018 – ABBOTT SAYS LAW ENFORCEMENT STILL SEARCHING, INVESTIGATING ENTIRE SCENE, LOOKING AT TWO RESIDENCES; 06/03/2018 – U.S. FDA SAYS GRANTED APPROVAL OF MASTER SERIES HEART VALVE TO ST JUDE MEDICAL; 11/04/2018 – Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in T; 11/04/2018 – Abbott Initiates Groundbreaking Study to Assess Superiority of High-Resolution Imaging Versus Standard-of-Care Angiography in; 23/04/2018 – ABBOTT LABORATORIES – CO, SANQUIN SIGN MULTIPLE-YEAR CONTRACT FOR SUPPLY OF PRIMARY SEROLOGICAL EQUIPMENT AND CONSUMABLES; 07/03/2018 – Abbott’s Confirm Rx connects an insertable cardiac monitor to a smartphone app; 18/04/2018 – ABBOTT 1Q EARNINGS CALL ENDS; 20/04/2018 – Abbott Extends Title Sponsorship of Abbott World Marathon Majors through 2023; 15/05/2018 – AHL Adds Restaurant Brands, Buys More Abbott: 13F; 18/04/2018 – ABBOTT LABORATORIES – FORECASTS NET SPECIFIED ITEMS FOR FULL YEAR 2018 OF APPROXIMATELY $1.57 PER SHARE

Among 4 analysts covering Abbott Labs (NYSE:ABT), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Abbott Labs had 4 analyst reports since April 18, 2018 according to SRatingsIntel. On Wednesday, April 18 the stock rating was maintained by Jefferies with “Buy”. Citigroup maintained it with “Neutral” rating and $65 target in Tuesday, April 24 report. Stifel Nicolaus maintained Abbott Laboratories (NYSE:ABT) on Thursday, July 19 with “Buy” rating.

Another recent and important Abbott Laboratories (NYSE:ABT) news was published by Seekingalpha.com which published an article titled: “If AbbVie Is A Buy, What About Abbott?” on July 20, 2018.

Since February 16, 2018, it had 1 insider buy, and 21 insider sales for $8.90 million activity. $16,369 worth of Abbott Laboratories (NYSE:ABT) was sold by Bracken Sharon J. Funck Robert E had sold 1,220 shares worth $71,970. The insider Fussell Stephen R sold $667,804. Shares for $58,635 were sold by Watkin Jared on Wednesday, February 28. BIRD ROGER had sold 8,262 shares worth $518,450 on Friday, March 9. Contreras Jaime sold $50,397 worth of stock. 3,000 shares valued at $183,592 were sold by Salvadori Daniel Gesua Sive on Thursday, May 17.

Investors sentiment decreased to 0.83 in Q1 2018. Its down 0.08, from 0.91 in 2017Q4. It worsened, as 44 investors sold ABT shares while 606 reduced holdings. 126 funds opened positions while 411 raised stakes. 1.22 billion shares or 0.54% more from 1.22 billion shares in 2017Q4 were reported. Hilltop Holdg, a Texas-based fund reported 7,631 shares. Afam Inc, Texas-based fund reported 135,479 shares. First Republic Inv Mngmt Inc invested 0.05% in Abbott Laboratories (NYSE:ABT). Timber Creek Cap Mgmt Ltd Liability has invested 0.02% of its portfolio in Abbott Laboratories (NYSE:ABT). Legal & General Gp Plc reported 0.36% stake. Systematic Fincl Mngmt Limited Partnership has invested 0% in Abbott Laboratories (NYSE:ABT). L S Advisors holds 0.24% or 21,348 shares in its portfolio. State Of Tennessee Treasury Department holds 1.14 million shares. Lingohr And Partner Asset Mngmt Gmbh owns 7,400 shares or 0.28% of their US portfolio. Buffington Mohr Mcneal owns 76,690 shares. Ohio-based Cincinnati Ins Communications has invested 2.09% in Abbott Laboratories (NYSE:ABT). Inr Advisory Serv Ltd Company invested 0% of its portfolio in Abbott Laboratories (NYSE:ABT). Nomura reported 0.03% in Abbott Laboratories (NYSE:ABT). Hardman Johnston Global Advsrs Llc has 0.13% invested in Abbott Laboratories (NYSE:ABT). Whittier Tru has invested 0.7% of its portfolio in Abbott Laboratories (NYSE:ABT).

Electrocomponents plc, together with its subsidiaries, distributes various electronics and industrial products in Northern Europe, Southern Europe, Central Europe, the Asia Pacific, North America, and internationally. The company has market cap of 3.37 billion GBP. The firm distributes semiconductor products, including microcontrollers, voltage regulators, transistors, and diodes; and interconnectors, passives, and electromechanical components, such as resistors, switches, and heavy-duty connectors for industrial applications and power supplies. It has a 22.62 P/E ratio. It also provides automation and control products comprising programmable logic controllers, safety devices, sensors, cables, and pneumatic cylinders for various vertical markets that include the food and beverage, packaging, manufacturing, marine, and gas and oil industries; and tools and consumables, which comprise electronics workbench equipment, electrostatic discharge products and 3D printers, and mechanical tools and lighting, as well as electrical, test, and measurement and safety equipment.

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: